
Trump Tariffs Loom—But Pharma Warns EU: Don’t Retaliate
Ahead of possible levies starting next week, a leading drug trade association claims a trade war would only deepen its problems.

Ahead of possible levies starting next week, a leading drug trade association claims a trade war would only deepen its problems.

Washington will lift “restrictive measures” while Beijing will “review and approve” items under export controls.
According to U.S. Commerce Secretary Howard Lutnick, the framework deal puts “meat on the bones” of an agreement reached last month in Geneva.
Germany’s central bank warns that a full-blown trade war with the U.S. could shrink the country’s economy in both 2025 and 2026, mainly due to falling exports and weakened business confidence.
European Commissioner for Trade Maroš Šefčovič said the tariffs hike does not help the negotiations between the U.S. and the EU.
Brussels have warned their counterparts that they are ready to employ tariffs of their own.

The free world should embrace the open flow of investment capital and business ideas, not stifle them with political suspicion.

Europe has no clue what Trump’s game is, and member states are fed up with being left in the dark.
The proposed new tax does nothing to disabuse Americans of the belief that Europeans favor protectionism over free trade.
The CEO of the Volkswagen Group and Porsche was pleased with the talks, but said he is keeping the details confidential.